Cancer is still one of the most common diseases in the world. What exactly is cancer and will we one day be able to cure everyone? In a video from the Universiteit van Nederland Noel de Miranda (Tumour Immunology, LUMC) tells you about his research on new treatments.

We already know a lot about genetics and the risk of breast cancer. But much still needs to be done in breast cancer genetics to improve the prognosis and make sure women at high risk aren’t missed. This is what Professor by Special Appointment Marjanka Schmidt will say in her inaugural lecture on 4…

An annual plan ensures that Planning & Control is embedded in the organisation. The plan states who provides what and when. This means that the right information is available at the right time, allowing for the proper financial management of the University.

To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…

Leiden University Medical Center (LUMC) has spent the past five years coordinating an international study of genetic mutations and breast cancer risks. The results will make it easier to determine which genes increase the risk of breast cancer and to what extent. The researchers published their results…

Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer.

In our new strategic plan (Innovating and Connecting – 2022-2027) we focus on stronger connections: between disciplines, with society and within our university community.

The university has developed a vision on education, Learning@LeidenUniversity. This vision together with the strategic plans from both the university and the faculty provide direction for our education.

When internist Christian Blank made his very first discovery, his field of immunotherapy was the underdog of cancer research. Now, over 20 years later, Blank has been appointed Professor By Special Appointment of Internal Medicine for his clinical research into immunotherapy and will give his inaugural…

If you’re planning to organise an event within the university, the information on this page will help you get started.

If you’re planning to organise an event within the university, the information on this page will help you get started.

A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.

Didactics, Career development

An important question being asked, both in the academic world and in society, concerns the impact of our research and education. By providing a well-supported answer, we not only create a strong position for our research, we also increase our chances of success in applying for research grants and retaining…

An important question being asked, both in the academic world and in society, concerns the impact of our research and education. By providing a well-supported answer, we not only create a strong position for our research, we also increase our chances of success in applying for research grants and retaining…

Career development, Transferable skills

On 11 November Professor of Gastroenterology and Hepatology, Monique van Leerdam will deliver her inaugural lecture entitled, ‘Aiming for Prevention’. Van Leerdam, who specialises in hereditary tumours, was appointed professor in July 2020. In her inaugural lecture she will discuss the importance of…

Researchers from the Leiden University Medical Center (LUMC) have developed an AI model that accurately predicts the risk of endometrial cancer recurrence.

Workshop

Workshop

Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.

How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.

One in two people will be diagnosed with cancer. World Cancer Day on 4 February raises awareness of the impact of this devastating disease. Leiden University is conducting various studies aimed at preventing and controlling cancer. Below are just a few examples.

Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.

Half of all people with cancer in the Netherlands are aged 70 or older, and as the population continues to age, this number will only rise. Yet vulnerable older people with cancer are often overlooked, says PhD candidate Joosje Baltussen.

Leiden University Libraries (UBL) recently issued a new collection policy plan, containing priorities for the coming years regarding the formation, management, availability, and use of the UBL collection.

In 2021, more than 2,600 students and staff members shared their ideas for Leiden University and the Strategic Plan for the coming years, under the banner of LDN>>>FWD. What will be the guiding principle for taking decisions? Which aspects will be emphasised? The last consultations have now been concluded…